News

Azenta Authorizes $250 Million Share Repurchase Program

BURLINGTON, Mass., Dec. 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its Board of Directors has approved…

2 weeks ago

SkinSight™ AI by ModuleMD: Smarter Skin Analysis, Faster Clinical Decisions

GRAND BLANC, Mich., Dec. 10, 2025 /PRNewswire/ -- ModuleMD, ranked as one of America's fastest-growing companies on the Inc. 5000…

2 weeks ago

Stellar Health and CenterLight Healthcare Announce Partnership to Enable Providers And Improve Health Outcomes for New York Seniors

NEW YORK, Dec. 10, 2025 /PRNewswire/ -- Stellar Health, a healthcare technology company focused on revolutionizing value-based care, today announced…

2 weeks ago

Competition Bureau obtains a court order to advance investigation into WELL Health’s acquisition of HEALWELL

GATINEAU, QC, Dec. 10, 2025 /CNW/ - The Competition Bureau has obtained a court order to gather information to advance…

2 weeks ago

TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board

A renowned expert in insulin pharmacology, diabetes technology, and temperature-sensitive medication stability joins TempraMed to strengthen scientific leadershipVancouver, British Columbia--(Newsfile…

2 weeks ago

Defence Therapeutics Announces AGM Results and Provides Corporate Updates

Montreal, Quebec--(Newsfile Corp. - December 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the…

2 weeks ago

CLS Health Strengthens Its Community Care Network in Southeast Houston and Pasadena

More top doctors joined the region's leading physician-owned healthcare group in 2025, increasing patients' access to primary care and medical…

2 weeks ago

AAMI Foundation Launches Michael Scholla Packaging Engineering Scholarship Fund

Calls for Contributions to Support Future Medical Device & Pharmaceutical Packaging LeadersArlington, Virginia--(Newsfile Corp. - December 10, 2025) - The…

2 weeks ago

Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000

Calgary, Alberta--(Newsfile Corp. - December 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"),…

2 weeks ago

Joe Albe, Ph.D., joins Washington Research Foundation as manager of grants and venture research

Albe brings extensive immunology and translational research experience to his full-time role working with WRF's grant, investment and venture analyst…

2 weeks ago